Stutzman D - Search Results

1

Pitolisant in an Adolescent with Prader-Willi Syndrome.

Pennington S, Stutzman D, Sannar E. Pennington S, et al. Among authors: stutzman d. J Pediatr Pharmacol Ther. 2021;26(4):405-410. doi: 10.5863/1551-6776-26.4.405. Epub 2021 May 19. J Pediatr Pharmacol Ther. 2021. PMID: 34035686 Free PMC article.

2

The Use of N-acetylcysteine Supplementation to Decrease Irritability in Four Youths With Autism Spectrum Disorders.

Pesko MJ, Burbige EM, Sannar EM, Beresford C, Rogers C, Ariefdjohan M, Stutzman D. Pesko MJ, et al. Among authors: stutzman d. J Pediatr Pharmacol Ther. 2020;25(2):149-154. doi: 10.5863/1551-6776-25.2.149. J Pediatr Pharmacol Ther. 2020. PMID: 32071590 Free PMC article.

3

Olanzapine-Induced Withdrawal Oculogyric Crisis in an Adolescent With a Neurodevelopmental Disorder.

Liuzzo K, Stutzman D, Murphy J. Liuzzo K, et al. Among authors: stutzman d. J Pediatr Pharmacol Ther. 2020;25(5):455-458. doi: 10.5863/1551-6776-25.5.455. J Pediatr Pharmacol Ther. 2020. PMID: 32641917 Free PMC article.

4

The Utility of Pharmacogenetic-Guided Psychotropic Medication Selection for Pediatric Patients: A Retrospective Study.

Ariefdjohan M, Lee YM, Stutzman DL, LeNoue S, Wamboldt MZ. Ariefdjohan M, et al. Among authors: stutzman dl. Pediatr Rep. 2021 Jul 28;13(3):421-433. doi: 10.3390/pediatric13030049. Pediatr Rep. 2021. PMID: 34449718 Free PMC article.

5

Five Steps to Improve Cardiac Safety of Attention Deficit Hyperactivity Disorder Treatment.

Dopheide JA, Stutzman DL. Dopheide JA, et al. Among authors: stutzman dl. J Pediatr Pharmacol Ther. 2024 Dec;29(6):670-673. doi: 10.5863/1551-6776-29.6.670. Epub 2024 Dec 9. J Pediatr Pharmacol Ther. 2024. PMID: 39659855 Free PMC article. No abstract available.

6

Acetylcysteine for treatment of autism spectrum disorder symptoms.

Stutzman D, Dopheide J. Stutzman D, et al. Am J Health Syst Pharm. 2015 Nov 15;72(22):1956-9. doi: 10.2146/ajhp150072. Am J Health Syst Pharm. 2015. PMID: 26541950

7

Providers' perspectives on the clinical utility of pharmacogenomic testing in pediatric patients.

Liko I, Lee YM, Stutzman DL, Blackmer AB, Deininger KM, Reynolds AM, Aquilante CL. Liko I, et al. Among authors: stutzman dl. Pharmacogenomics. 2021 Apr;22(5):263-274. doi: 10.2217/pgs-2020-0112. Epub 2021 Mar 4. Pharmacogenomics. 2021. PMID: 33657875 Free PMC article.

8

Practice Pearls for Stimulant Treatment of Attention-Deficit/Hyperactivity Disorder in Youth.

Stutzman DL, Dopheide JA. Stutzman DL, et al. J Pediatr Pharmacol Ther. 2024 Jun;29(3):215-231. doi: 10.5863/1551-6776-29.3.215. Epub 2024 Jun 10. J Pediatr Pharmacol Ther. 2024. PMID: 38863854 Free PMC article.

9

L-methylfolate Augmentation to Antidepressants for Adolescents with Treatment-Resistant Depression: A Case Series.

Dartois LL, Stutzman DL, Morrow M. Dartois LL, et al. Among authors: stutzman dl. J Child Adolesc Psychopharmacol. 2019 Jun;29(5):386-391. doi: 10.1089/cap.2019.0006. Epub 2019 May 6. J Child Adolesc Psychopharmacol. 2019. PMID: 31058543

10

Impact of Pharmacogenomics on Pediatric Psychotropic Medication Prescribing in an Ambulatory Care Setting.

Tonti E, Lee YM, Gruenke N, Ferren J, Stutzman DL. Tonti E, et al. Among authors: stutzman dl. J Child Adolesc Psychopharmacol. 2024 Feb;34(1):52-60. doi: 10.1089/cap.2023.0087. J Child Adolesc Psychopharmacol. 2024. PMID: 38377527

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters